The analyses suggested that most of these inflammation-related pathways were significantly down-regulated in CRC tissue compared to paired normal tissue irrespective of sex, stage, grade, MSI status or KRAS mutation status. The gene discussed is KRAS; the disease is colorectal carcinoma.